Keisuke Shirakura

447 total citations
17 papers, 227 citations indexed

About

Keisuke Shirakura is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Keisuke Shirakura has authored 17 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Keisuke Shirakura's work include Angiogenesis and VEGF in Cancer (7 papers), Axon Guidance and Neuronal Signaling (5 papers) and Barrier Structure and Function Studies (4 papers). Keisuke Shirakura is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Axon Guidance and Neuronal Signaling (5 papers) and Barrier Structure and Function Studies (4 papers). Keisuke Shirakura collaborates with scholars based in Japan, United States and Germany. Keisuke Shirakura's co-authors include Yoshiaki Okada, Takefumi Doi, Masuo Kondoh, Yosuke Hashimoto, Hiroyuki Takeda, Kiyohito Yagi, Nobumasa Hino, William C. Aird, Toru Tanaka and Tatsuya Sawasaki and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Keisuke Shirakura

16 papers receiving 225 citations

Peers

Countries citing papers authored by Keisuke Shirakura

Since Specialization

Citations

This map shows the geographic impact of Keisuke Shirakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Shirakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Shirakura more than expected).

Fields of papers citing papers by Keisuke Shirakura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Shirakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Shirakura. The network helps show where Keisuke Shirakura may publish in the future.

Co-authorship network of co-authors of Keisuke Shirakura

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Shirakura. A scholar is included among the top collaborators of Keisuke Shirakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Shirakura. Keisuke Shirakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	VE-PTP controls a fluid shear stress set point that governs cell morphological responses through Tie-2 2025 ·Frontiers in Cell and Developmental Biology ·Keisuke Shirakura, (unknown), Kevin G. Peters, Dietmar Vestweber	0
2	Tie-2 regulates endothelial morphological responses to shear stress by FOXO1-triggered autophagy 2025 ·PLoS ONE ·(unknown), Keisuke Shirakura, Dietmar Vestweber	2
3	Endothelial ROBO4 suppresses PTGS2/COX-2 expression and inflammatory diseases 2024 ·Communications Biology ·Masato Tanaka, Keisuke Shirakura, (unknown), (unknown), (unknown), Takuya Yamamoto, (unknown), Shota Tanaka, Nobumasa Hino, Takefumi Doi, Masanori Obana, Yasushi Fujio, Kazuo Takayama, Yoshiaki Okada	8
4	Conditions that promote transcellular neutrophil migration in vivo 2024 ·Scientific Reports ·Min Xia, (unknown), Keisuke Shirakura, Stefan Butz, Aude Thiriot, Ulrich H. von Andrian, Dietmar Vestweber	1
5	Shear stress control of vascular leaks and atheromas through Tie2 activation by VE‐PTP sequestration 2023 ·EMBO Molecular Medicine ·Keisuke Shirakura, Peter Bałuk, Astrid F. Nottebaum, Ute Ipe, Kevin G. Peters, Donald M. McDonald, Dietmar Vestweber	22
6	Heterogeneity of endothelial VE-PTP downstream polarization, Tie2 activation, junctional claudin-5, and permeability in the aorta and vena cava 2023 ·Cell and Tissue Research ·Peter Bałuk, Keisuke Shirakura, Dietmar Vestweber, Donald M. McDonald	2
7	HDAC inhibitor, MS-275, increases vascular permeability by suppressing Robo4 expression in endothelial cells 2021 ·Tissue Barriers ·(unknown), Keisuke Shirakura, (unknown), (unknown), (unknown), (unknown), (unknown), Masato Tanaka, (unknown), Nobumasa Hino, Shohei Koyama, Ryo Suzuki, Yasuo Yoshioka, Taiki Aoshi, Takefumi Doi, Yoshiaki Okada	12
8	Safety and efficacy of an anti-claudin-5 monoclonal antibody to increase blood–brain barrier permeability for drug delivery to the brain in a non-human primate 2021 ·Journal of Controlled Release ·Keisuke Tachibana, Yosuke Hashimoto, Keisuke Shirakura, Yoshiaki Okada, Ryuichi Hirayama, (unknown), (unknown), Yukio Ago, Hiroyuki Takeda, Hiroki Kuniyasu, Masuo Kondoh	19
9	Vascular Leakage Prevention by Roundabout 4 under Pathological Conditions 2021 ·Biological and Pharmaceutical Bulletin ·Keisuke Shirakura, Yoshiaki Okada	2
10	PRC2 Components Maintain DNA Hypermethylation of the Upstream Promoter and Regulate Robo4 Expression in Endothelial Cells 2020 ·Biological and Pharmaceutical Bulletin ·(unknown), Keisuke Shirakura, (unknown), Nobuaki Funahashi, (unknown), Nobumasa Hino, Toru Tanaka, Takefumi Doi, Yoshiaki Okada	3
11	The Robo4-TRAF7 complex suppresses endothelial hyperpermeability in inflammation 2018 ·Journal of Cell Science ·Keisuke Shirakura, (unknown), (unknown), (unknown), Toru Tanaka, So‐ichiro Fukada, Kenji Ishimoto, Nobumasa Hino, Masuo Kondoh, Yukio Ago, Yasushi Fujio, Kiichiro Yano, Takefumi Doi, William C. Aird, Yoshiaki Okada	22
12	Engineered membrane protein antigens successfully induce antibodies against extracellular regions of claudin-5 2018 ·Scientific Reports ·Yosuke Hashimoto, Wei Zhou, (unknown), Keisuke Shirakura, Takefumi Doi, Kiyohito Yagi, Tatsuya Sawasaki, Yoshiaki Okada, Masuo Kondoh, Hiroyuki Takeda	29
13	ETV2-TET1/TET2 Complexes Induce Endothelial Cell-Specific Robo4 Expression via Promoter Demethylation 2018 ·Scientific Reports ·Toru Tanaka, (unknown), (unknown), (unknown), Atsumasa Okada, Tomoko Yamaguchi, Keisuke Shirakura, (unknown), Hayato Matsui, Kenji Ishimoto, Nobumasa Hino, Osamu Nakagawa, William C. Aird, Hiroyuki Mizuguchi, Kenji Kawabata, Takefumi Doi, Yoshiaki Okada	25
14	Anti-Claudin Antibodies as a Concept for Development of Claudin-Directed Drugs 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Yosuke Hashimoto, Yoshiaki Okada, Keisuke Shirakura, Keisuke Tachibana, Makoto Sawada, Kiyohito Yagi, Takefumi Doi, Masuo Kondoh	11
15	Claudin-5-Binders Enhance Permeation of Solutes across the Blood-Brain Barrier in a Mammalian Model 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Yosuke Hashimoto, Keisuke Shirakura, Yoshiaki Okada, Hiroyuki Takeda, Kohki Endo, (unknown), Akihiro Watari, Yoshifusa Sadamura, Tatsuya Sawasaki, Takefumi Doi, Kiyohito Yagi, Masuo Kondoh	34
16	Endothelial Robo4 regulates IL-6 production by endothelial cells and monocytes via a crosstalk mechanism in inflammation 2017 ·Biochemical and Biophysical Research Communications ·Keisuke Shirakura, (unknown), (unknown), (unknown), (unknown), Nana Yamamoto, (unknown), (unknown), Toru Tanaka, Nobumasa Hino, William C. Aird, Takefumi Doi, Yoshiaki Okada	23
17	Tumor Necrosis Factor α Induces the Expression of the Endothelial Cell-Specific Receptor Roundabout4 through the Nuclear Factor-κB Pathway 2017 ·Biological and Pharmaceutical Bulletin ·Toru Tanaka, (unknown), (unknown), (unknown), (unknown), Keisuke Shirakura, Kenji Ishimoto, Nobumasa Hino, William C. Aird, Takefumi Doi, Yoshiaki Okada	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact